NeuroMetrix, Inc. Announces Date for First Quarter 2019 Financial Results Conference Call

NEXT STORY
Elixinol and KBMD Health Launch New Hemp CBD Extract
PREV STORY
Genmab Announces Data to be Presented at 2019 ASCO Annual Meeting
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

TG Therapeutics Announces Publication of Results from an Integrated Safety Analysis of UKONIQ® (umbralisib) in Blood Advances

author_avatar
NASDAQ Market News

Predictive Oncology Subsidiary, Helomics, Signs Collaborative Research Agreement with ChemImage to Expand Personalized Medicine to Prostate Cancer Prognosis and Treatment

author_avatar
NASDAQ Market News

Chi-Med Announces NDA Acceptance in China for Savolitinib in the Treatment of Non-Small Cell Lung Cancer with MET Exon 14 Skipping Mutations

author_avatar
NASDAQ Market News